InnoCare Pharma Ltd. Financial Overview
InnoCare Pharma Ltd.'s market cap is currently HK$19.59B. The company's EPS TTM is HK$-0.021897962; its P/E ratio is -92.85; InnoCare Pharma Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is HK$0.35. See an overview of income statement, balance sheet, and cash flow financials.
